I was in Seattle for the week at the Society for Biomaterials 2019 conference. Excited to have data from three projects in four sessions at SFB 2019. Thanks to CTSI-PDT (#CTSI), ACS-IRG(#americancersociety), NDnano, AD&T and HCRI for their crucial support for these projects. 1. Rapid-Fire oral Presentation on Wednesday on April 3, 2019, from 4:05 …
Category Archive: metastatic cancer cells
Feb 14
American Cancer Society Seed Grant Awarded to us to Develop a Label-Free, Precise Chemotherapeutic Delivery to Metastatic Breast Cancer Cells In Vivo
AD&T Notre Dame, American Cancer Society, Berthiaume Institute for Precision Health, chemotherapeutics, Harper Cancer Research Institute, Label-free, magnetoelectrics, metastatic cancer cells
by Prakash
We are extremely excited and thankful to the American Cancer Society and the Harper Cancer Research Institute for facilitating this seed grant for our work on label-free targeting of undruggable cancer cells. We intend to target non-targetable cancer cells by tuning the force exerted by label-free nanomaterials at the cell membrane to selectively permeabilize the …
Tags: NDNano
Aug 30
Nanoparticles that act as an “ON and OFF” switch to improve the safety and effectiveness of CAR-T cancer therapy
AD&T Notre Dame, Berthiaume Institute for Precision Health, Combination chemotherapy, Harper Cancer Research Institute, Immunotherapy, metastatic cancer cells
by Prakash
Always thankful for the internal support from Notre Dame Research #notredameresearch for supporting high risk-high gain projects such as mine. Here’s hoping that my faculty research support program initiation grant (FRSP-IG) #FRSP will pave the way for safer, more accessible CAR-T therapies and better quality of life for patients. https://research.nd.edu/news/developing-an-on-and-off-switch-for-breast-cancer-treatment/ The biggest bottle neck in Chimeric …
Tags: NDNano
Jul 02
Inaugural Woodward family endowment for excellence in NDNANO undergraduate research awarded to Margo Waters
AD&T Notre Dame, Berthiaume Institute for Precision Health, Cancer stem cells, Combination chemotherapy, Harper Cancer Research Institute, metastatic cancer cells
by Prakash
Congratulations to Margo Waters of the Nallathamby lab for having being selected for the Inaugural Woodward family endowment for excellence in NDnano undergraduate research! Margo has been an exceptional contributor to advancing research on novel cancer therapeutics in our lab. You can check out more about what motivates her at https://research.nd.edu/news/inaugural-woodward-family-endowment-for-excellence-in-ndnano-undergraduate-research-awarded/
Tags: NDNano
Recent Posts
- Phage-Mimicking Antibacterial Nanoparticles Tackle Group A Streptococcal Infections In Vivo January 29, 2024
- 2nd Annual Berthiaume Institute for Precision Health’s Advisory Board Meeting October 30, 2023
- 1st Place Poster at the Military Health Sciences Research Symposium 2023 (Aug 14-17, Kissimmee, FL) August 14, 2023
- Congratulations to Ms. Johanna Olesk on Defending her MS (Bioengineering) ’23 Thesis July 7, 2023
- Translational Science to Impact Public Health was our Goal at Techconnect 2023 June 17, 2023
Archives
Categories
NIH Funding Opportunities
- Notice of Clarification of NIMH Specific Areas of Research Interest in PAR-24-144 and PAR-24-145, "Support for Research Excellence (SuRE) and (SuRE-First) Awards (R16 - Clinical Trial Not Allowed) April 23, 2024Notice NOT-MH-24-250 from the NIH Guide for Grants and Contracts
- NIDA MERIT Awards for Early Stage Investigators (ESI) April 23, 2024Notice NOT-DA-24-017 from the NIH Guide for Grants and Contracts
- Phase-out and Termination of NIDA MERIT Awards for Established Investigators April 23, 2024Notice NOT-DA-24-016 from the NIH Guide for Grants and Contracts
- Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2024 April 23, 2024Notice NOT-OD-24-104 from the NIH Guide for Grants and Contracts
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) April 23, 2024Funding Opportunity PA-24-191 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support […]
- Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required) April 23, 2024Funding Opportunity PA-24-192 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support […]
- Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) April 23, 2024Funding Opportunity PA-24-190 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support […]
- Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) April 23, 2024Funding Opportunity RFA-AI-24-017 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research that 1) defines associations between variations in human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, 2) elucidates mechanisms underlying these associations with the goal […]
- Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional) April 23, 2024Funding Opportunity RFA-DK-25-010 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for Cystic Fibrosis (CF) Research and Translation Core Centers. CF Research and Translation Core Centers are designed to support both basic and clinical research on Cystic Fibrosis. CF Research and Translation Core Centers support three primary […]
- Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed) April 23, 2024Funding Opportunity RFA-CA-24-023 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. Both small businesses and universities are drivers of […]
Recent Comments